Logo image of ALBIZ.PA

OBIZ SA (ALBIZ.PA) Stock Fundamental Analysis

EPA:ALBIZ - Euronext Paris - Matif - FR0014003711 - Common Stock - Currency: EUR

3.78  -0.1 (-2.58%)

Fundamental Rating

3

ALBIZ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 66 industry peers in the Media industry. While ALBIZ seems to be doing ok healthwise, there are quite some concerns on its profitability. ALBIZ is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALBIZ had negative earnings in the past year.
ALBIZ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALBIZ reported negative net income in multiple years.
Of the past 5 years ALBIZ 4 years had a positive operating cash flow.
ALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

ALBIZ has a Return On Assets of -4.69%. This is in the lower half of the industry: ALBIZ underperforms 72.73% of its industry peers.
ALBIZ has a worse Return On Equity (-21.64%) than 74.24% of its industry peers.
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALBIZ.PA Yearly ROA, ROE, ROICALBIZ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Gross Margin of ALBIZ (13.37%) is worse than 84.85% of its industry peers.
In the last couple of years the Gross Margin of ALBIZ has declined.
The Profit Margin and Operating Margin are not available for ALBIZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
ALBIZ.PA Yearly Profit, Operating, Gross MarginsALBIZ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

ALBIZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBIZ has more shares outstanding
Compared to 5 years ago, ALBIZ has more shares outstanding
The debt/assets ratio for ALBIZ has been reduced compared to a year ago.
ALBIZ.PA Yearly Shares OutstandingALBIZ.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALBIZ.PA Yearly Total Debt VS Total AssetsALBIZ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ALBIZ has an Altman-Z score of 2.82. This is not the best score and indicates that ALBIZ is in the grey zone with still only limited risk for bankruptcy at the moment.
ALBIZ has a Altman-Z score of 2.82. This is amongst the best in the industry. ALBIZ outperforms 90.91% of its industry peers.
A Debt/Equity ratio of 1.70 is on the high side and indicates that ALBIZ has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.70, ALBIZ is doing worse than 75.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z 2.82
ROIC/WACCN/A
WACC5.95%
ALBIZ.PA Yearly LT Debt VS Equity VS FCFALBIZ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 2.17 indicates that ALBIZ has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.17, ALBIZ belongs to the top of the industry, outperforming 92.42% of the companies in the same industry.
A Quick Ratio of 1.90 indicates that ALBIZ should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.90, ALBIZ belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.9
ALBIZ.PA Yearly Current Assets VS Current LiabilitesALBIZ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

The earnings per share for ALBIZ have decreased strongly by -2780.72% in the last year.
The Revenue has grown by 51.46% in the past year. This is a very strong growth!
ALBIZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.67% yearly.
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%

3.2 Future

The Earnings Per Share is expected to grow by 292.43% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALBIZ will show a small growth in Revenue. The Revenue will grow by 6.63% on average per year.
EPS Next Y920%
EPS Next 2Y292.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.07%
Revenue Next 2Y7.33%
Revenue Next 3Y6.33%
Revenue Next 5Y6.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALBIZ.PA Yearly Revenue VS EstimatesALBIZ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ALBIZ.PA Yearly EPS VS EstimatesALBIZ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.1 0.2 0.3

3

4. Valuation

4.1 Price/Earnings Ratio

ALBIZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALBIZ is valuated correctly with a Price/Forward Earnings ratio of 14.39.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBIZ is on the same level as its industry peers.
ALBIZ is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.33, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 14.39
ALBIZ.PA Price Earnings VS Forward Price EarningsALBIZ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALBIZ indicates a slightly more expensive valuation: ALBIZ is more expensive than 68.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.64
ALBIZ.PA Per share dataALBIZ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ALBIZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALBIZ's earnings are expected to grow with 292.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y292.43%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALBIZ!.
Industry RankSector Rank
Dividend Yield N/A

OBIZ SA

EPA:ALBIZ (7/15/2025, 7:00:00 PM)

3.78

-0.1 (-2.58%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners53.65%
Ins Owner ChangeN/A
Market Cap22.19M
Analysts87.27
Price Target8.3 (119.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-17.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-17.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.39
P/S 0.18
P/FCF N/A
P/OCF 21.26
P/B 1.85
P/tB N/A
EV/EBITDA 17.64
EPS(TTM)-0.44
EYN/A
EPS(NY)0.26
Fwd EY6.95%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.18
OCFY4.7%
SpS21.44
BVpS2.04
TBVpS-2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.37%
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
F-Score4
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA 9.61
Cap/Depr 119.21%
Cap/Sales 2.2%
Interest Coverage N/A
Cash Conversion 49.18%
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.9
Altman-Z 2.82
F-Score4
WACC5.95%
ROIC/WACCN/A
Cap/Depr(3y)85.83%
Cap/Depr(5y)92.26%
Cap/Sales(3y)2.18%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
EPS Next Y920%
EPS Next 2Y292.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%
Revenue Next Year8.07%
Revenue Next 2Y7.33%
Revenue Next 3Y6.33%
Revenue Next 5Y6.63%
EBIT growth 1Y-120.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year209.24%
EBIT Next 3Y91.94%
EBIT Next 5Y57.12%
FCF growth 1Y-434.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.6%
OCF growth 3YN/A
OCF growth 5Y4.44%